Cite
HARVARD Citation
Atzler, M. et al. (n.d.). Increased detection of (leukemiaspecific) adaptive and innate immune-reactive cells under treatment of AML-diseased rats and one therapy-refractory AML-patient with blastmodulating, clinically approved response modifiers. European journal of cancer. pp. S28-S29. [Online].